208 related articles for article (PubMed ID: 11175751)
1. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.
Tzung SP; Kim KM; Basañez G; Giedt CD; Simon J; Zimmerberg J; Zhang KY; Hockenbery DM
Nat Cell Biol; 2001 Feb; 3(2):183-91. PubMed ID: 11175751
[TBL] [Abstract][Full Text] [Related]
2. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L).
Vieira HL; Boya P; Cohen I; El Hamel C; Haouzi D; Druillenec S; Belzacq AS; Brenner C; Roques B; Kroemer G
Oncogene; 2002 Mar; 21(13):1963-77. PubMed ID: 11960369
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2/E1B 19 kDa-interacting protein 3-like protein (Bnip3L) interacts with bcl-2/Bcl-xL and induces apoptosis by altering mitochondrial membrane permeability.
Imazu T; Shimizu S; Tagami S; Matsushima M; Nakamura Y; Miki T; Okuyama A; Tsujimoto Y
Oncogene; 1999 Aug; 18(32):4523-9. PubMed ID: 10467396
[TBL] [Abstract][Full Text] [Related]
4. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine.
Boya P; Gonzalez-Polo RA; Poncet D; Andreau K; Vieira HL; Roumier T; Perfettini JL; Kroemer G
Oncogene; 2003 Jun; 22(25):3927-36. PubMed ID: 12813466
[TBL] [Abstract][Full Text] [Related]
6. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.
Lindenboim L; Borner C; Stein R
Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors.
Shimizu S; Eguchi Y; Kamiike W; Waguri S; Uchiyama Y; Matsuda H; Tsujimoto Y
Oncogene; 1996 Jul; 13(1):21-9. PubMed ID: 8700549
[TBL] [Abstract][Full Text] [Related]
8. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
10. VDAC2 inhibits BAK activation and mitochondrial apoptosis.
Cheng EH; Sheiko TV; Fisher JK; Craigen WJ; Korsmeyer SJ
Science; 2003 Jul; 301(5632):513-7. PubMed ID: 12881569
[TBL] [Abstract][Full Text] [Related]
11. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
Hao JH; Yu M; Liu FT; Newland AC; Jia L
Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
[TBL] [Abstract][Full Text] [Related]
13. Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2.
Simonian PL; Grillot DA; Nuñez G
Oncogene; 1997 Oct; 15(15):1871-5. PubMed ID: 9362454
[TBL] [Abstract][Full Text] [Related]
14. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
[TBL] [Abstract][Full Text] [Related]
16. Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax.
Xiao D; Zeng Y; Choi S; Lew KL; Nelson JB; Singh SV
Clin Cancer Res; 2005 Apr; 11(7):2670-9. PubMed ID: 15814648
[TBL] [Abstract][Full Text] [Related]
17. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway.
Deng W; Wang DA; Gosmanova E; Johnson LR; Tigyi G
Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G821-9. PubMed ID: 12684213
[TBL] [Abstract][Full Text] [Related]
18. FAST is a BCL-X(L)-associated mitochondrial protein.
Li W; Kedersha N; Chen S; Gilks N; Lee G; Anderson P
Biochem Biophys Res Commun; 2004 May; 318(1):95-102. PubMed ID: 15110758
[TBL] [Abstract][Full Text] [Related]
19. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.
Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA
Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
